The Report Guru

The medical wearables market is projected to reach USD 19.5 billion by 2025 from USD 7.4 billion in 2020, at a CAGR of 21.4% during the forecast period. The growing demand for advanced clinical-grade wearables to streamline complex operational procedures among healthcare organizations has led to a number of product launches & enhancements in recent years. Companies focus on launching innovative solutions to gain a competitive edge and exploit market growth opportunities offered by advanced and next-generation wearables. The prominent players in this market are Medtronic plc. (Ireland), Koninklijke Philips N.V. (Netherlands), OMRON Corporation (Japan), Biotelemetry Inc.(US), Apple, Inc. (US ), Dexcom  Inc. (US),  Abbott Laboratories(US), Masimo Corporation(US), GE Healthcare (US), Bio-Beat Technologies (Israel), iRhythm Technologies, Inc.(US), VitalConnect (US), Minttihealth (US), Preventice Solutions, Inc. (US), Contec Medical Systems Co.Ltd(China), Biotrici...

The global in vitro toxicology testing market is set to experience significant growth, with the market projected to reach USD 18.6 billion by 2027 from USD 11.2 billion in 2022, growing at a CAGR of 10.8%. The key drivers of this growth include increasing R&D expenditure to detect toxicity at an early stage during drug development, as well as the pharmaceutical and cosmetics industries' increasing focus on using in vitro methods. This market is highly competitive, with key players such as Thermo Fisher Scientific, Merck KGaA, and Laboratory Corporation of America Holdings focusing on increasing their presence in high-growth markets through organic and inorganic growth strategies. Thermo Fisher Scientific is a leading player in the in vitro toxicology testing market, providing laboratory equipment, analytical instruments, consumables, services, and reagents. With a strong global sales and distribution network, the company operates from the Life Science Business se...

The oral care market has been witnessing remarkable growth in recent years and is expected to continue this trend over the next few years, with a projected growth from USD 47.2 billion in 2021 to USD 54.9 billion in 2026, at a CAGR of 3.1%. This growth can be attributed to various factors, such as an increase in the incidence of dental diseases, a rise in the number of practicing dentists globally, and technological advancements in oral care products. However, the oral care market also faces several challenges, such as product recalls that have the potential to restrain the market's growth, and the adverse effects of teeth whitening products that pose a significant challenge. The market is highly consolidated, with major players such as Colgate-Palmolive Company, Procter Gamble, GlaxoSmithKline plc, Koninklijke Philips N.V., Johnson Johnson, and Unilever plc dominating the market. These players have adopted various strategies to enhance their presence in the oral car...

The global overactive bladder treatment market is expected to witness significant growth in the coming years. According to the latest market research report, the market is projected to reach USD 4.2 billion by 2027, growing at a CAGR of 3.6% during the forecast period from 2022 to 2027. This growth can be attributed to several factors such as the rising prevalence of overactive bladder syndrome across the world and the launch of novel drugs with lesser side-effects. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219938791 In addition, the adoption of technologically advanced treatment options for OAB treatment is also expected to support market growth in the coming years. This has led to increased competition among the market players, with several companies adopting various strategies to sustain market competition. Astellas Pharma, Teva Pharmaceutical Industries, Pfizer, Medtronic, AbbVie, Viatris, Hisamitsu Pharmaceutical, Johnson Johnso...

The global restorative dentistry market is witnessing a significant growth trajectory and is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1% during the forecast period. The growth of this market can be attributed to several factors, including a rise in the number of tooth repair procedures, increasing demand for advanced cosmetic dental procedures, and growing interest in dental tourism in emerging countries. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210042423 Additionally, the development of technologically advanced solutions in restorative dentistry, such as CAD/CAM technologies, is also driving market growth. These technologies are being increasingly adopted by the dental industry due to their precision and accuracy, which helps to improve the efficiency of dental restoration procedures. Despite the market's growth prospects, there are some factors that may hinder market growth to ...

The global immunohistochemistry market is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period of 2021 to 2026. Market growth is largely driven by the rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, technological advancements in IHC, and availability of reimbursements for IHC tests. However, the high degree of consolidation in the by the major market players is expected to restrain the growth of this market during the forecast period. The global immunohistochemistry market is highly competitive. Prominent players operating in the global immunohistochemistry market include F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), and Agilent Technologies, Inc. (US). The key players in this market are increasingly focusing on strategic expansions, partnerships, and product launches and approvals to expand their product and geographic footprint and incr...

The oral care market is expected to see a significant increase in value over the next few years, with a projected growth from USD 47.2 billion in 2021 to USD 54.9 billion in 2026, at a CAGR of 3.1%. The growth of this market can be attributed to various factors, such as the rising incidence of dental diseases, an increasing number of practicing dentists globally, and technological advancements in oral care products. However, the oral care market also faces some challenges. For instance, product recalls have the potential to restrain the growth of the market, while the adverse effects of teeth whitening products pose a significant challenge. The market is highly consolidated, with major players such as Colgate-Palmolive Company, Procter Gamble, GlaxoSmithKline plc, Koninklijke Philips N.V., Johnson Johnson, and Unilever plc dominating the market. These players have adopted various strategies such as acquisitions, partnerships, agreements, collaborations, expansions, and ...